nature.com search

Loading Filters

Showing 1–21 of 21 results

Loading Filters

16 March 2006
Late first relapses in APL treated with all-trans-retinoic acid- and anthracycline- based chemotherapy: the European APL group experience (APL 91 and APL 93 trials)
- C Kelaidi
- , L Ades
- , S Chevret
- , M Sanz
- , A Guerci
- , X Thomas
- , S de Botton
- , E Raffoux
- , C Rayon
- , N Fegueux
- , D Bordessoule
- , F Rigal-Huguet
- , H Link
- , A Stoppa
- , A Vekhoff
- , S Meyer-Monard
- , S Castaigne
- , H Dombret
- , L Degos
- & P Fenaux
Leukemia 20 , 905–907

Rights & permissionsfor article Late first relapses in APL treated with all-trans-retinoic acid- and anthracycline- based chemotherapy: the European APL group experience (APL 91 and APL 93 trials) . Opens in a new window.
6 April 2006
Autoimmune hemolytic anemias and IgG antierythrocyte autoantibodies in Waldenström's macroglobulinemia: association with FcγRIIa polymorphism
- S Poulain
- , I Dervite
- , X Leleu
- , J Fernandes
- , L Stalnikiewicz
- , A-S Moreau
- , V Coiteux
- , S de Botton
- , P Duthilleul
- & P Morel
Leukemia 20 , 1179–1181

Rights & permissionsfor article Autoimmune hemolytic anemias and IgG antierythrocyte autoantibodies in Waldenström's macroglobulinemia: association with FcγRIIa polymorphism . Opens in a new window.
8 November 2011
SF3B1 mutations in myelodysplastic syndromes: clinical associations and prognostic implications
- F Damm
- , F Thol
- , O Kosmider
- , S Kade
- , P Löffeld
- , F Dreyfus
- , A Stamatoullas-Bastard
- , A Tanguy-Schmidt
- , O Beyne-Rauzy
- , S de Botton
- , A Guerci-Bresler
- , G Göhring
- , B Schlegelberger
- , A Ganser
- , O A Bernard
- , M Fontenay
- & M Heuser
Leukemia 26 , 1137–1140

Rights & permissionsfor article SF3B1 mutations in myelodysplastic syndromes: clinical associations and prognostic implications . Opens in a new window.
5 February 2013
SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias
- F Damm
- , R Itzykson
- , O Kosmider
- , N Droin
- , A Renneville
- , V Chesnais
- , V Gelsi-Boyer
- , S de Botton
- , N Vey
- , C Preudhomme
- , A Clavert
- , E Delabesse
- , S Park
- , D Birnbaum
- , M Fontenay
- , O A Bernard
- & E Solary
Leukemia 27 , 1401–1403

Rights & permissionsfor article SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias . Opens in a new window.
27 May 2010
Prognostic value of minimal residual disease by real-time quantitative PCR in acute myeloid leukemia with CBFB-MYH11 rearrangement: the French experience
- R Guièze
- , A Renneville
- , J-M Cayuela
- , R B Abdelali
- , N Boissel
- , S de Botton
- , M-T Rubio
- , F Mazingue
- , E A Macintyre
- , M Cheok
- , F Sigaux
- , P Fenaux
- , H Dombret
- & C Preudhomme
Leukemia 24 , 1386–1388

Rights & permissionsfor article Prognostic value of minimal residual disease by real-time quantitative PCR in acute myeloid leukemia with CBFB-MYH11 rearrangement: the French experience . Opens in a new window.
18 February 2003
Early onset of chemotherapy can reduce the incidence of ATRA syndrome in newly diagnosed acute promyelocytic leukemia (APL) with low white blood cell counts: results from APL 93 trial
- S de Botton
- , S Chevret
- , V Coiteux
- , H Dombret
- , M Sanz
- , J San Miguel
- , D Caillot
- , A Vekhoff
- , M Gardembas
- , A Stamatoulas
- , E Conde
- , A Guerci
- , C Gardin
- , M Fey
- , D Cony Makhoul
- , O Reman
- , J de la Serna
- , F Lefrere
- , C Chomienne
- , L Degos
- & P Fenaux
Leukemia 17 , 339–342

Rights & permissionsfor article Early onset of chemotherapy can reduce the incidence of ATRA syndrome in newly diagnosed acute promyelocytic leukemia (APL) with low white blood cell counts: results from APL 93 trial . Opens in a new window.
Research | 12 October 2006
Allogeneic stem cell transplantation improves the outcome of adults with t(1;19)/E2A-PBX1 and t(4;11)/MLL-AF4 positive B-cell acute lymphoblastic leukemia: results of the prospective multicenter LALA-94 study
- N Vey
- , X Thomas
- , C Picard
- , T Kovascovicz
- , C Charin
- , J M Cayuela
- , H Dombret
- , N Dastugue
- , F Huguet
- , C Bastard
- , A Stamatoulas
- , M Giollant
- , O Tournilhac
- , E Macintyre
- , A Buzyn
- , D Bories
- , M Kuentz
- , F Dreyfus
- , A Delannoy
- , S Raynaud
- , N Gratecos
- , D Bordessoule
- , S de Botton
- , C Preudhomme
- , O Reman
- , X Troussard
- , A Pigneux
- , C Bilhou
- , J P Vernant
- , C Boucheix
- & J Gabert
Leukemia 20 , 2155–2161

Rights & permissionsfor article Allogeneic stem cell transplantation improves the outcome of adults with t(1;19)/E2A-PBX1 and t(4;11)/MLL-AF4 positive B-cell acute lymphoblastic leukemia: results of the prospective multicenter LALA-94 study . Opens in a new window.
Research | 28 February 2005
Allogeneic stem cell transplantation in second rather than first complete remission in selected patients with good-risk acute myeloid leukemia
- A de Labarthe
- , C Pautas
- , X Thomas
- , S de Botton
- , D Bordessoule
- , H Tilly
- , T de Revel
- , C Bastard
- , C Preudhomme
- , M Michallet
- , P Fenaux
- , J-N Bastie
- , G Socié
- , C Cordonnier
- & H Dombret
Bone Marrow Transplantation 35 , 767–773

Rights & permissionsfor article Allogeneic stem cell transplantation in second rather than first complete remission in selected patients with good-risk acute myeloid leukemia . Opens in a new window.
27 January 2005
Prognostic value of real-time quantitative PCR (RQ-PCR) in AML with t(8;21)
- H Leroy
- , S de Botton
- , N Grardel-Duflos
- , S Darre
- , X Leleu
- , C Roumier
- , F Morschhauser
- , J -L Lai
- , F Bauters
- , P Fenaux
- & C Preudhomme
Leukemia 19 , 367–372

Rights & permissionsfor article Prognostic value of real-time quantitative PCR (RQ-PCR) in AML with t(8;21) . Opens in a new window.
Research | 19 October 2006
High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa group
- A-L Taksin
- , O Legrand
- , E Raffoux
- , T de Revel
- , X Thomas
- , N Contentin
- , R Bouabdallah
- , C Pautas
- , P Turlure
- , O Reman
- , C Gardin
- , B Varet
- , S de Botton
- , F Pousset
- , H Farhat
- , S Chevret
- , H Dombret
- & S Castaigne
Leukemia 21 , 66–71

Rights & permissionsfor article High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa group . Opens in a new window.
25 November 2004
Outcome of acute promyelocytic leukemia treated with all trans retinoic acid and chemotherapy in elderly patients: the European group experience
- L Ades
- , S Chevret
- , S De Botton
- , X Thomas
- , H Dombret
- , B Beve
- , M Sanz
- , A Guerci
- , J S Miguel
- , J dela Serna
- , C Garo
- , A M Stoppa
- , O Reman
- , A Stamatoulas
- , M Fey
- , J Y Cahn
- , J J Sotto
- , J H Bourhis
- , A Parry
- , C Chomienne
- , L Degos
- & P Fenaux
Leukemia 19 , 230–233

Rights & permissionsfor article Outcome of acute promyelocytic leukemia treated with all trans retinoic acid and chemotherapy in elderly patients: the European group experience . Opens in a new window.
Research | 24 November 2005
Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy
- S de Botton
- , M A Sanz
- , S Chevret
- , H Dombret
- , G Martin
- , X Thomas
- , J D Mediavilla
- , C Recher
- , L Ades
- , B Quesnel
- , P Brault
- , M Fey
- , H Wandt
- , D Machover
- , A Guerci
- , F Maloisel
- , A M Stoppa
- , C Rayon
- , J M Ribera
- , C Chomienne
- , L Degos
- & P Fenaux
Leukemia 20 , 35–41

Rights & permissionsfor article Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy . Opens in a new window.
Research | 6 April 2006
Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML)
- N Boissel
- , H Leroy
- , B Brethon
- , N Philippe
- , S de Botton
- , A Auvrignon
- , E Raffoux
- , T Leblanc
- , X Thomas
- , O Hermine
- , B Quesnel
- , A Baruchel
- , G Leverger
- , H Dombret
- & C Preudhomme
Leukemia 20 , 965–970

Rights & permissionsfor article Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML) . Opens in a new window.
12 May 2005
Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group
- C Callens
- , S Chevret
- , J-M Cayuela
- , B Cassinat
- , E Raffoux
- , S de Botton
- , X Thomas
- , A Guerci
- , N Fegueux
- , A Pigneux
- , A-M Stoppa
- , T Lamy
- , F Rigal-Huguet
- , A Vekhoff
- , S Meyer-Monard
- , A Ferrand
- , M Sanz
- , C Chomienne
- , P Fenaux
- & H Dombret
Leukemia 19 , 1153–1160

Rights & permissionsfor article Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group . Opens in a new window.
Research | 25 January 2007
Effect of priming with granulocyte–macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group
- X Thomas
- , E Raffoux
- , S de Botton
- , C Pautas
- , P Arnaud
- , T de Revel
- , O Reman
- , C Terré
- , B Corront
- , C Gardin
- , Q-H Le
- , B Quesnel
- , C Cordonnier
- , J-H Bourhis
- , M Elhamri
- , P Fenaux
- , C Preudhomme
- , M Michallet
- , S Castaigne
- & H Dombret
Leukemia 21 , 453–461

Rights & permissionsfor article Effect of priming with granulocyte–macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group . Opens in a new window.
Research | 22 October 2012
Azacytidine and erlotinib exert synergistic effects against acute myeloid leukemia
- E Lainey
- , A Wolfromm
- , N Marie
- , D Enot
- , M Scoazec
- , C Bouteloup
- , C Leroy
- , J-B Micol
- , S De Botton
- , L Galluzzi
- , P Fenaux
- & G Kroemer
Oncogene 32 , 4331–4342

Rights & permissionsfor article Azacytidine and erlotinib exert synergistic effects against acute myeloid leukemia . Opens in a new window.
Research | 4 October 2012 | Open
CXCR4 inhibitors selectively eliminate CXCR4-expressing human acute myeloid leukemia cells in NOG mouse model
- Y Zhang
- , S Patel
- , H Abdelouahab
- , M Wittner
- , C Willekens
- , S Shen
- , A Betems
- , V Joulin
- , P Opolon
- , O Bawa
- , F Pasquier
- , M Ito
- , N Fujii
- , P Gonin
- , E Solary
- , W Vainchenker
- , P Coppo
- , S De Botton
- & F Louache
Cell Death & Disease 3 , e396–e396

Rights & permissionsfor article CXCR4 inhibitors selectively eliminate CXCR4-expressing human acute myeloid leukemia cells in NOG mouse model . Opens in a new window.
Research | 27 April 2009
Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndrome
- S Boehrer
- , L Adès
- , N Tajeddine
- , W K Hofmann
- , S Kriener
- , G Bug
- , O G Ottmann
- , M Ruthardt
- , L Galluzzi
- , C Fouassier
- , M Tailler
- , K A Olaussen
- , C Gardin
- , V Eclache
- , S de Botton
- , S Thepot
- , P Fenaux
- & G Kroemer
Oncogene 28 , 2205–2218

Rights & permissionsfor article Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndrome . Opens in a new window.
Research | 2 December 2010 | Open
Calreticulin exposure on malignant blasts predicts a cellular anticancer immune response in patients with acute myeloid leukemia
- M Wemeau
- , O Kepp
- , A Tesnière
- , T Panaretakis
- , C Flament
- , S De Botton
- , L Zitvogel
- , G Kroemer
- & N Chaput
Cell Death & Disease 1 , e104–e104

Rights & permissionsfor article Calreticulin exposure on malignant blasts predicts a cellular anticancer immune response in patients with acute myeloid leukemia . Opens in a new window.
Research | 15 December 2008
ATM mediates constitutive NF-κB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia
- J Grosjean-Raillard
- , M Tailler
- , L Adès
- , J-L Perfettini
- , C Fabre
- , T Braun
- , S De Botton
- , P Fenaux
- & G Kroemer
Oncogene 28 , 1099–1109

Rights & permissionsfor article ATM mediates constitutive NF-κB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia . Opens in a new window.
Research | 13 January 2012
Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association
- A Renneville
- , N Boissel
- , O Nibourel
- , C Berthon
- , N Helevaut
- , C Gardin
- , J-M Cayuela
- , S Hayette
- , O Reman
- , N Contentin
- , D Bordessoule
- , C Pautas
- , S de Botton
- , T de Revel
- , C Terre
- , P Fenaux
- , X Thomas
- , S Castaigne
- , H Dombret
- & C Preudhomme
Leukemia 26 , 1247–1254

Rights & permissionsfor article Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association . Opens in a new window.

Refine your results by…

Filters

Filter By:

Late first relapses in APL treated with all-trans-retinoic acid- and anthracycline- based chemotherapy: the European APL group experience (APL 91 and APL 93 trials)

Autoimmune hemolytic anemias and IgG antierythrocyte autoantibodies in Waldenström's macroglobulinemia: association with FcγRIIa polymorphism

SF3B1 mutations in myelodysplastic syndromes: clinical associations and prognostic implications

SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias

Prognostic value of minimal residual disease by real-time quantitative PCR in acute myeloid leukemia with CBFB-MYH11 rearrangement: the French experience

Early onset of chemotherapy can reduce the incidence of ATRA syndrome in newly diagnosed acute promyelocytic leukemia (APL) with low white blood cell counts: results from APL 93 trial

Allogeneic stem cell transplantation improves the outcome of adults with t(1;19)/E2A-PBX1 and t(4;11)/MLL-AF4 positive B-cell acute lymphoblastic leukemia: results of the prospective multicenter LALA-94 study

Allogeneic stem cell transplantation in second rather than first complete remission in selected patients with good-risk acute myeloid leukemia

Prognostic value of real-time quantitative PCR (RQ-PCR) in AML with t(8;21)

High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa group

Outcome of acute promyelocytic leukemia treated with all trans retinoic acid and chemotherapy in elderly patients: the European group experience

Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy

Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML)

Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group

Effect of priming with granulocyte–macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group

Azacytidine and erlotinib exert synergistic effects against acute myeloid leukemia

CXCR4 inhibitors selectively eliminate CXCR4-expressing human acute myeloid leukemia cells in NOG mouse model

Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndrome

Calreticulin exposure on malignant blasts predicts a cellular anticancer immune response in patients with acute myeloid leukemia

ATM mediates constitutive NF-κB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia

Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association

Quick links

Refine your results by…

Filters ​

Filter By:

Search

Quick links

Filters